Volume Alert - COV 96.94 Covidien Plc. $COV Hit a high

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 2:08 PM

Volume Alert - COV 96.94 Covidien Plc. $COV Hit a high today of 97.19 Closing the day 10:30 at 96.94 -0.56 -0.57% With a day low of 96.65 and a total volume of 1,085,692.

COV Recent Posts: http://investorshangout.com/Covidien-Plc-COV-50596/

COV Covidien Plc. Recent Headline News

Tracking John Paulson's Paulson & Company Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Thu Nov 20, 12:49AM CST

RKT: 55.82 (-0.08), KOG: 10.14 (+0.38), MEAS: 86.00 (+0.01), HHC: 147.81 (+1.89), AET: 86.01 (+0.46), DLPH: 71.03 (-0.07), DLTR: 65.83 (+3.20), AEM: 26.80 (+0.75), AUXL: 33.15 (+0.12), DG: 66.96 (+0.86), ABBV: 65.40 (-0.10), DXM: 8.28 (+0.02), MNK: 86.72 (+0.74), ATHL: 58.40 (unch), NCQ: 0.70 (+0.01), COV: 97.46 (-0.04), AU: 9.50 (+0.16), MYL: 55.29 (-0.39), IAG: 2.23 (+0.02), FDO: 78.40 (-0.05), MGM: 22.24 (+0.05), GNW: 9.22 (+0.09), HIG: 40.82 (+0.02), NG: 2.89 (+0.09), EQIX: 221.42 (-4.26), HSH: 62.96 (unch), OAS: 26.63 (+0.78), PETM: 78.04 (-0.15), ACT: 259.80 (-6.24), MDT: 71.73 (-0.03), BPOP: 31.83 (-0.17), ENZY: 8.35 (-0.05), FCX: 28.41 (+0.33), GFI: 4.22 (+0.13), CZR: 15.10 (+0.73), CVC: 18.85 (-0.08), CIE: 10.82 (+0.69), CACQ: 10.41 (+0.22), AGN: 210.11 (-2.48), ECA: 18.08 (+0.28), FCH: 10.25 (+0.19), R: 90.81 (+0.26), DTV: 87.08 (-0.14), KMDA: 3.27 (-0.12), ANV: 1.71 (+0.22), MOVE: 20.95 (-0.03), BAC: 16.96 (-0.10), GRFS: 36.63 (+0.25), POST: 35.93 (+0.39), HCA: 67.46 (+0.42), RDN: 16.89 (+0.16), BEE: 12.97 (+0.03), CPWR: 10.27 (+0.11), GLD: 114.52 (+0.84), RLGY: 44.17 (+1.23), MTG: 9.23 (+0.26), HMHC: 19.99 (+0.05), CMCSA: 54.32 (-0.06), CBS: 53.81 (+0.47), BABA: 111.03 (+2.21)

Covidien Achieves CE Mark for the Nellcor(TM) Bedside SpO2 Patient Monitoring System, PM100N
Business Wire - Wed Nov 19, 11:01PM CST
Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor(TM) Bedside SpO2 Patient Monitoring System, PM100N. The system currently is available in the European Economic Area (EEA), Australia and New Zealand. The Nellcor(TM) Bedside SpO2 Patient Monitoring System is the only commercially available bedside pulse oximetry (SpO2) monitor featuring home care and sleep study modes that complies with standards for medical electrical equipment used in the home health care environment.
COV: 97.46 (-0.04)

Mallinckrodt Earnings Beat But No New Guidance
at Investor's Business Daily - Wed Nov 19, 10:42AM CST
Specialty drugmaker Mallinckrodt beat analysts' expectations handily in its fiscal Q4 report, but it didn't provide hoped-for guidance in the wake of an FDA decision that hits one of its best-selling drugs. Mallinckrodt (MNK) stock was down 4% in...
MNK: 86.72 (+0.74), JNJ: 108.11 (-0.65), ACT: 259.80 (-6.24), COV: 97.46 (-0.04)

Uptrend Call Working As Covidien Stock Rises 36.0% (COV)
Comtex SmarTrend(R) - Wed Nov 19, 9:45AM CST
SmarTrend identified an Uptrend for Covidien (NYSE:COV) on May 12th, 2014 at $72.16. In approximately 6 months, Covidien has returned 35.96% as of today's recent price of $98.11.
COV: 97.46 (-0.04)

Stock Market News for November 19, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 9:10AM CST
Rally in healthcare stocks and easing global growth worries boosted benchmarks to finish in the green on Tuesday
URBN: 31.51 (+1.98), AGN: 210.11 (-2.48), HD: 97.72 (+1.02), ACT: 259.80 (-6.24), GILD: 101.39 (-0.95), PFE: 30.45 (+0.01), COV: 97.46 (-0.04), ALXN: 191.68 (-0.28)

Announcement under Irish Takeover Rules Relevant Securities in Issue - November 19, 2014
Business Wire - Wed Nov 19, 8:41AM CST
In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the "Company"

confirms that, as of the close of business on November 18, 2014, the Company's issued share capital, excluding treasury shares, consisted of 452,731,347 ordinary shares, par value US$0.20 per share (the "Ordinary Shares"

. The International Securities Identification Number (ISIN) of the Ordinary Shares is IE00B68SQD29.
COV: 97.46 (-0.04)

Medtronic digesting purchases
at Investor's Business Daily - Tue Nov 18, 5:43PM CST
The medical device giant delivered a solid fiscal Q2 report as EPS rose 5% to 96 cents, in line with estimates, on a 4% hike in revenue to $3.67 bil, also meeting estimates. Medtronic (MDT), which is digesting several small acquisitions, said it's...
MDT: 71.73 (-0.03), COV: 97.46 (-0.04)

SmarTrend Watching for Potential Pullback in Shares of Covidien After 3.68% Gain
Comtex SmarTrend(R) - Tue Nov 18, 3:53PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $94.66 to a high of $98.32. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high of $94.90 on volume of 4.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 97.46 (-0.04)

Look for Shares of Covidien to Potentially Pullback after Yesterday's 3.68% Rise
Comtex SmarTrend(R) - Tue Nov 18, 3:53PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $94.66 to a high of $98.32. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high of $94.90 on volume of 4.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 97.46 (-0.04)

Medtronic (MDT) Posts In Line Earnings, Revenues Beat in Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 11:21AM CST
Medtronic Inc.'s (MDT) second-quarter fiscal 2015 adjusted earnings per share (EPS) came in at 96 cents.
BSX: 12.88 (-0.21), MDT: 71.73 (-0.03), ABAX: 52.65 (-1.42), COV: 97.46 (-0.04)

See Why Medtronic Stock Is Surging Today
Sure Dividend - at Seeking Alpha - Tue Nov 18, 10:15AM CST

MDT: 71.73 (-0.03), COV: 97.46 (-0.04)

Medtronic Earnings In Line; Sales Guidance Up
at Investor's Business Daily - Tue Nov 18, 9:55AM CST
Medical-device giant Medtronic (MDT) early Tuesday delivered a solid quarter and modestly bullish revenue guidance as it digests several small acquisitions and prepares for a huge one. Medtronic was up 3.5% in early trading in the stock market today,...
MDT: 71.73 (-0.03), COV: 97.46 (-0.04), STJ: 64.08 (+0.11)

InsiderInsights.com Daily Round Up 11/17/14: SFM, INTX, GNRC, GSAT
InsiderInsights - at Seeking Alpha - Tue Nov 18, 5:55AM CST

HCOM: 25.98 (-0.10), IPHI: 14.75 (+0.31), JBHT: 80.95 (+0.83), COV: 97.46 (-0.04), OPHT: 40.48 (+0.38), COP: 72.95 (+0.82), SFM: 31.52 (+0.09), GOOG: 534.80 (-2.19), GSAT: 2.60 (-0.07), STAY: 18.47 (-0.17), ZOES: 34.19 (+1.05), INTX: 3.77 (+0.04), GNRC: 43.51 (+0.02), HZNP: 12.21 (-0.41), TRUE: 18.06 (+0.48)

Covidien's Test Data Positive for VenaSeal Closure System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:10PM CST
Covidien plc (COV) recently announced six-month results from the VeClose pivotal study, which was carried out to evaluate the safety and efficiency of the VenaSeal closure system, a treatment option for chronic venous disorders.
JNJ: 108.11 (-0.65), BDX: 130.16 (+0.05), BCR: 166.79 (+0.12), COV: 97.46 (-0.04)

Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015
Thomson Reuters ONE - Mon Nov 17, 11:30AM CST

MDT: 71.73 (-0.03), COV: 97.46 (-0.04)

Six Month Results of VeClose Study Demonstrate Safety, Effectiveness of the VenaSeal(TM) Closure System
Business Wire - Thu Nov 13, 5:00PM CST
Covidien plc (NYSE:COV) today announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal(TM) closure system* in patients with chronic venous insufficiency (CVI) having symptomatic reflux in the great saphenous vein. The results were presented at American College of Phlebology Annual Congress (ACP 2014) in Phoenix, Ariz.
COV: 97.46 (-0.04)

Form 8.1 - Covidien
Business Wire - Thu Nov 13, 10:17AM CST
Covidien plc:
COV: 97.46 (-0.04)

Insider Trading Alert - CTSH, PSEC And COV Traded By Insiders
at The Street - Thu Nov 13, 9:15AM CST
Stocks with insider trader activity include CTSH, PSEC and COV
COV: 97.46 (-0.04), CTSH: 51.76 (-0.67), PSEC: 9.67 (+0.02)

Covidien Shares Up 28.9% Since SmarTrend's Buy Recommendation (COV)
Comtex SmarTrend(R) - Wed Nov 12, 9:16AM CST
SmarTrend identified an Uptrend for Covidien (NYSE:COV) on May 12th, 2014 at $72.16. In approximately 6 months, Covidien has returned 28.91% as of today's recent price of $93.02.
COV: 97.46 (-0.04)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Millrose Faces Class Action: Blame Game in Motion

Millrose Properties: A Realty Ruckus Unfolding Sometimes, in the world of stocks, it feels like you're two steps ahead of the scam or already knee-deep in trouble. Millrose Properties, Inc. struck a rather sour chord recently with an 8.53% stock drop, leaving investors feeling the burn. Here's the juice: a securities fraud class action is in motion, and if you're holding...

Mili and Egnyte Transform Financial Advice Delivery

AI Powers Up Financial Advisors with New Partnership Ah, the grind never ends for those financial advisors, right? Well, here's a nugget that might just lighten their load. Mili and Egnyte are buddying up to merge AI with secure content platforms, aiming to supercharge how advisors handle client documents. Right off the bat, advisors can crank out personalized advice at a...

Hemlo Mining's Q3 2026: Challenges and New Solutions

Resilience in the Face of Operational Setbacks Here's a peek into Hemlo Mining's latest exploits. They're riding a rollercoaster of operational challenges, yet still managing to chug along with stable gold production. It's like trying to drive uphill with a flat tire, but somehow, Hemlo's trucking along without missing too much of a beat. The numbers are in, and despite a...

Dan-O's Seasoning Bags $25M to Spice Up Global Kitchens

Spicing Up The Investment Scene Who would've thought a humble seasoning mix could steal the show in the investment world, eh? Dan-O's Seasoning, that quirky little flavor brand from Louisville, just pulled a $25 million rabbit out of the hat with an investment from The Newcastle Network. That's news worth chewing on. From Farmers Market to Flavor Giant Let's flash back a...

Equity Alerts: Unraveling the Latest M&A Surprises

Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...

Minesto Joins Sweden-Indonesia Partnership in Energy Shift

Minesto's Big Splash in Indonesia's Energy Transition Here we go, folks. Minesto's taking the plunge into Indonesia's uncharted tidal waters under a Sweden-backed partnership. This Swedish underdog in ocean energy is ready to shake things up and ride the Indonesian currents, thanks to the Sweden-Indonesia Sustainability Partnership. Now, why should this matter to you, the...

Microencapsulation Market to Hit $24B by 2031

Think about wrapping a tiny gift inside a bubble that's not only protective but also dissolves at just the right moment. That, my friends, is microencapsulation summed up—and it's becoming a big deal. With the market poised to jump from $16.90 billion in 2026 to a whopping $24.02 billion by 2031, at a steady clip of 7.3% annually, there's a lot for investors to chew on...

European Flavors: A Halloween Food Revolution

Who would've thought Halloween would toss a spin on fine dining? What's usually known for candy corn and spooky costumes has teamed up with European flavors for a night unlike any other. And we're talking more than just trick-or-treating here, folks. A New Kind of Halloween Spread This year, The Charming Taste of Europe has thrown itself into the Halloween festivities,...

New American Perspectives Shines at HIFF 2026

Ever notice how the arts can cut through the noise and spotlight voices we often overlook? Well, that's exactly what's happening at the Hawai?i International Film Festival (HIFF) this year. The Vilcek Foundation, alongside HIFF, is bringing the New American Perspectives program back for another round at the festival’s 46th edition, and it's a heck of a lineup....

Highlight's Pulse Offers Real-Time Consumer Insights

Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...